Merck & Co Inc (MRK)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

$99.75

Buy

$100.30

arrow-up$1.29 (+1.30%)

Prices updated at 13 Dec 2025, 00:56 EST
| Prices minimum 15 mins delay
|
Prices in USD

Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.

Income statement

20232024
60,115m64,168m
43,989m48,975m
2,954m20,221m
4.9131.51
365m17,117m
6,907m25,706m
Sales, General and administrative10,504m10,816m
Interest expenses1,146m1,271m
Provision for income taxes1,512m2,803m
Operating expenses41,035m28,754m
Income before taxes1,889m19,936m
Net income available to common shareholders365m17,117m
0.146.76
Net interest income-781m-856m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.146.74
Free cash flow per share5.16615.8368
Book value/share16.292217.6062
Debt equity ratio0.8962770.744111

Balance sheet

20232024
Current assets32,168m38,782m
Current liabilities25,694m28,420m
Total capital71,264m80,775m
Total debt35,055m37,111m
Total equity37,581m46,313m
Total non current liabilities--
Loans33,683m34,462m
Total assets106,675m117,106m
Total liabilities--
Cash and cash equivalents6,841m13,242m
Common stock2,532m2,528m

Cash flow

20232024
Cash at beginning of period12,773m6,909m
Cash dividends paid-7,445m-7,840m
9,143m18,096m
Investments (gains) losses-14,083m-7,734m
6,909m13,318m
Net income--
13,006m21,468m
-3,863m-3,372m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.